Ovarian cancer is a silent disease with a poor prognosis that urgently requires new therapeutic strategies. In low-grade ovarian tumours, mutations in the MAP3K BRAF gene constitutively activate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback